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Abstract Amyloid beta-protein (Ab) is the major com-
ponent of senile plaques and cerebrovascular amyloid
deposits in individuals with Alzheimer’s disease. Ab is
known to increase free radical production in neuronal cells,
leading to oxidative stress and cell death. Recently, con-
siderable attention has been focused on dietary antioxidants
that are able to scavenge reactive oxygen species (ROS),
thereby offering protection against oxidative stress.
Walnuts are rich in components that have anti-oxidant and
anti-inﬂammatory properties. The inhibition of in vitro
ﬁbrillization of synthetic Ab, and solubilization of pre-
formed ﬁbrillar Ab by walnut extract was previously
reported. The present study was designed to investigate
whether walnut extract can protect against Ab-induced
oxidative damage and cytotoxicity. The effect of walnut
extractonAb-inducedcellulardamage,ROSgenerationand
apoptosis in PC12 pheochromocytoma cells was studied.
Walnut extract reduced Ab-mediated cell death assessed by
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
umbromide)reduction,andreleaseoflactatedehydrogenase
(membrane damage), DNA damage (apoptosis) and gener-
ation of ROS in a concentration-dependent manner.
These results suggest that walnut extract can counteract
Ab-induced oxidative stress and associated cell death.
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Introduction
Alzheimer’s disease (AD) is a severe neurodegenerative
disease that gradually results in loss of memory and
impairment of cognitive functions in the elderly. The
aggregation and ﬁbrillization of amyloid beta-protein (Aß),
leading to the deposition of amyloid plaques in the brain, is
one of the major pathological features in AD [1, 2]. The
mechanisms of neuronal cell loss in AD have not yet been
fully elucidated, but increased oxidative stress [3–14] and
inﬂammation [5, 14–16] are considered important initia-
tors/mediators of neuronal damage in AD. Extensive evi-
dence indicates that the brains of individuals with AD are
characterized by exaggerated oxidative stress [3, 4, 6, 7,
10–13], and the overproduction of Ab leads to Ab-asso-
ciated free-radical production and cell death [17–21]. Not
only does Aß increase oxidative stress, but its generation is
also increased as a result of oxidative stress, which in turn
causes more oxidative damage.
Ab ﬁbril formation is a multi-step process that is pre-
ceded by oligomerization and aggregation of monomeric
Ab, and it involves conformational change of the peptide
from alpha-helical to beta-pleated sheet structure [22].
Recent evidence suggests that soluble oligomers of Aß in
the brain are neurotoxic and a major risk factor for the
onset and progression of cognitive deterioration in AD
[23–25].
The potential beneﬁcial roles of dietary antioxidants
have been emphasized in various diseases including AD.
Walnuts (Juglans regia L.) are an excellent source of
a-linolenic acid (plant-based omega-3 fatty acid) and have
a high content of antioxidants such as ﬂavonoids, phenolic
acid (ellagic acid), melatonin, gamma tocopherol and
selenium [26–32]. In terms of antioxidant contents, walnuts
ranked second among 1,113 different food items tested
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DOI 10.1007/s11064-011-0533-z[33]. While most nuts contain monounsaturated fats, wal-
nuts comprise primarily polyunsaturated fat (13 g of 18 g
total fat in one ounce of walnuts), of which a-linolenic acid
is 2.5 g.
Green walnuts, shells, kernels and seeds, bark and leaves
have been used in the pharmaceutical and cosmetic
industries [34]. Walnuts and their leaves have been used in
traditional medicine for treatment of venous insufﬁciency
and haemorrhoidal symptomatology, and for their antidi-
arrheic, anti-microbial, antihelmintic, depurative and
astringent properties [35–37]. The keratolytic, antifungal,
hypoglycemic, hypotensive and sedative activities of wal-
nuts have also been reported [27, 36]. Several studies have
suggested that the consumption of walnuts in the diet can
reduce the risk of heart disease [38–41] and decrease total
and low-density lipoproteins (LDL) [39, 42–46]. In another
study, a polyphenolic-rich extract of walnuts was able to
protect LDL from oxidation [26]. A large cohort study of
83,818 women (age: 34–59 years) showed that consump-
tion of one-ounce portions of nuts, such as walnuts, or of
peanut butter ﬁve times or more each week signiﬁcantly
reduced the risk of developing type 2 diabetes [47]. Animal
studies showed that a diet rich in walnuts slowed the
growth of MDA-MB231 human breast cancers implanted
into nude mice [48], and oral administration of a poly-
phenolic-rich fraction of walnuts prevented liver damage in
mice [49].
An in vitro study has shown that walnut extract can
inhibit the ﬁbrillization of synthetic Aß and also solubilize
Aß ﬁbrils [50]. Although various phytochemical constitu-
ents and diverse medicinal activities have been attributed to
walnuts, biochemical studies have not been carried out to
study whether walnuts can protect against Ab-induced cell
death. PC12 Pheochromocytoma cells are widely used for
in vitro research on AD. These cells contain many mem-
brane-bound and cytosolic molecules associated with
neurons, and are electrically excitable and neurosecretory
[51, 52]. The present study was designed to analyze the
effect of walnut extract on Aß-induced cytotoxicity and
oxidative damage in PC12 cells.
Experimental Procedure
Materials
PC12 cell line was obtained from the American Type
Culture Collection (Manassas, VA). Ab (1–42) was pur-
chased from Anaspec (Fremont, CA). Dimethyl sulfoxide
(DMSO) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide (MTT) were purchased from Sigma
(St. Louis, MO). Dichloroﬂuorescin diacetate (DCFHDA),
RPMI 1640 medium, horse serum, fetal bovine serum and
antibiotic–antimycotic were purchased from Invitrogen
(Carlsbad, CA). Cell Death Detection ELISA
PLUS kit was
purchased from Roche Applied Science (Indianapolis, IN),
and assay kit for lactate dehydrogenase (LDH) was pur-
chased from Promega (Madison, WI). All other chemicals
and reagents were from Sigma.
Preparation of Walnut Extract
The walnut extract was prepared by the modiﬁed method of
Anderson et al. [26]. In brief, walnuts (30 g; approximately
six walnuts) were frozen for 24 h; the shelled kernel was
then immersed in 240 ml of 100 mM acetate buffer, pH
4.8/acetone (30:70, V/V). After incubation at 4C for 24 h,
the solutions were decanted, resulting in a cold extract.
This process was repeated. The two macerates were com-
bined and concentrated using a rotary evaporator under
reduced pressure at 37C until the organic solvent was
completely evaporated. The concentrated solution was
extracted three times with 75 ml ethyl acetate. The three
ethyl acetate extracts were combined and then evaporated
to remove ethyl acetate. A lyophilized powder of walnut
extract was obtained and dissolved in 25 mM Tris–HCl,
pH 7.4.
Measurement of Total Phenolics in Walnut Extract
To rule out the variation in different walnut preparations,
we measured the total phenolics in walnut extract and
expressed the concentration of walnut extract in terms of
gallic acid equivalent (GAE) to maintain the consistency of
samples. Total phenolics were measured by the Folin–Ci-
ocalteu assay [53]. Brieﬂy, the Folin–Ciocalteu reagent
was mixed with serial dilutions of walnut extract or gallic
acid standards, followed by incubation with 1.9 M sodium
carbonate. After 1 h, the absorbance at 765 nm was mea-
sured and compared with that of gallic acid standards. The
concentration of phenolics in walnut extract was expressed
as GAE.
Aggregation and Fibrillization of Amyloid Beta-Protein
Synthetic Ab 1–42 was solubilized in 25 mM Tris–HCl,
pH 7.4, and allowed to aggregate and ﬁbrillize by incu-
bating at room temperature for 72 h. The beta-pleated
structure of Ab was conﬁrmed by Thioﬂavin T (ThT)
ﬂuorescence spectroscopy, as described previously [54].
ThT does not bind to dimers or tetramers, but only binds to
higher-order Ab aggregates, protoﬁbrils and amyloid-like
ﬁbrils [55, 56]. When ThT binds to Ab, it ﬂuoresces at the
excitation and emission wavelengths of 435 and 485 nm,
respectively.
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PC12 cells were cultured and maintained as described
previously [57]. The growth medium consisted of RPMI
1640, 10% heat-inactivated horse serum, 5% fetal bovine
serum, 50 units/ml penicillin and 100 mg/ml streptomycin.
Cultures were maintained in the 37C incubator with water
saturated and 5% CO2. PC12 cells were passaged when the
culture was 80–90% conﬂuent, dislodged from the surface
of the culture dish (100 mm) and dispersed into a single
cell by triturating the culture medium directly onto the cells
repeatedly and forcefully. The cells were sub-cultured once
a week in the split ratio of 1:4. The viability of cells was
checked using trypan blue, and 95% of viable cells were
used for all the assays.
Effect of Walnut Extract on Ab-Induced Cell Death
and Oxidative Stress in PC12 Cells
Ab-mediated toxic effect was measured in the absence or
presence of walnut extract in PC12 cells by the following
methods.
MTT Reduction Assay for Cell Viability
Cellular viability was measured in a 96-well plate by
quantitative colorimetric assay with MTT, which is an
indicator of the mitochondrial activity of living cells [58].
It is reduced to formazan by mitochondrial respiratory
enzymes, and therefore, the amount of formazan produced
indicates the cell viability. PC12 cells were pretreated with
different concentrations of walnut extract (2 or 4 lg GAE),
and then exposed to 50 lMo r7 5lMA b 1–42 for 24 h.
After the medium was removed, the cells were incubated
with 0.25 mg/ml MTT for 4 h at 37C. The reaction was
stopped by adding DMSO. The amount of MTT formazan
product was determined by measuring absorbance in a
microplate reader at a test wavelength of 570 nm and a
reference wavelength of 630 nm.
LDH Release Assay for Cell Membrane Damage
LDH released into the medium is an index of cell mem-
brane damage because of the enzyme’s high intracellular
localization. The plasma membrane damage was evaluated
by measuring extracellular LDH activity in the medium.
PC12 cells were pretreated with different concentrations of
the walnut extract (2 or 4 lg GAE), and then exposed to 50
or 75 lMA b 1–42 for 24 h. After the incubation, 50 llo f
culture supernatants were collected from each well. The
LDH activity was determined with a colorimetric LDH
assay kit. Total cellular LDH activity was determined by
solubilizing the cell with 0.2% Triton X-100. The release
of intracellular LDH to the extracellular medium is
expressed as a percentage of total cellular LDH activity.
Assessment of DNA Damage for Apoptosis
There is enrichment of mono- and oligonucleosomes in the
cytoplasm of the apoptotic cells because DNA degradation
occurs several hours before plasma membrane breakdown
[59]. Assessment of apoptosis was done by using the Cell
Death Detection ELISA
PLUS kit. This assay is a photo-
metric enzyme-linked immunoassay, which measures
quantitatively the internucleosomal degradation of DNA
that occurs during apoptosis. Speciﬁcally, the assay detects
histone-associated DNA fragments (mono- and oligonu-
cleosomes), which are indicators of apoptosis. PC12 cells
were plated at a density of 10,000 cells per well in a
96-well plate, and allowed to attach for 12 h. The cells
were treated with walnut extract (2 or 4 lg GAE), and/or
Ab (50 or 75 lM) for 12 h. Following treatments, adherent
cells were washed with PBS (137 mM sodium chloride,
1.5 mM potassium phosphate, 7.2 mM sodium phosphate,
2.7 mM potassium chloride, pH 7.4). An equal number of
live cells was added to the microtiter plate for all treatment
groups, and apoptosis assay was performed according to
the manufacturer’s instructions.
Effect of Walnut Extract on Generation of Free Radicals
The levels of intracellular reactive oxygen species (ROS)
were determined by the change in ﬂuorescence resulting
from the oxidation of the ﬂuorescent probe DCFH-DA
[60]. When applied to intact cells, DCFH-DA readily dif-
fuses through the cell membrane and is hydrolyzed enzy-
matically by intracellular esterases to nonﬂuorescent
DCFH [61]. In the presence of ROS, DCFH is oxidized to
highly ﬂuorescent DCF [61]. DCF ﬂuorescent intensity is
proportional to the amount of ROS formed intracellularly.
In this assay, PC12 cells were pretreated with different
concentrations of the walnut extract, and then exposed to
50 or 75 lMA b 1–42 for 24 h. After the medium was
removed, the cells were incubated with 100 lM DCFH-DA
for 30 min, and the cells were washed to remove the
extracellular DCFH–DA. The cells were then suspended in
PBS. The ﬂuorescence intensity (relative ﬂuorescence unit)
was determined using a CytoFluor 4000 ﬂuorescence plate
reader at the excitation wavelength of 485 nm and emis-
sion wavelength of 535 nm.
Statistical Analysis
Data are expressed as mean ± SD for each group (n = 3).
The statistical signiﬁcance of changes in different groups
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123was evaluated by one way-ANOVA using GraphPad Prism
software. The statistical signiﬁcance at P\0.05 was
considered as signiﬁcant.
Results
Mean ± SD for different groups, i.e., control cells (no Ab),
Ab-treated cells, and the effect of different concentrations
of walnut extract (2 or 4 lg GAE) on control and Ab-
treated cells are represented in Figs. 1, 2, 3, 4. Table 1
summarizes the effects of walnut extract on Ab-induced
cell death and free radical generation.
Effect of Walnut Extract on Ab-Mediated Cytotoxicity
in PC12 Cells
Ab was found to induce cytotoxicity in PC12 cells, as
judged by MTT assay and LDH release. MTT reduction
assay showed that Ab 1–42 induced cytotoxicity and sig-
niﬁcantly reduced cell viability (P\0.001) by 60% at
50 lM, and by 62.1% at 75 lM concentrations of Ab as
compared to control cells (no Ab). The pretreatment of the
cells with walnut extract (2 and 4 lg GAE) resulted in the
reduction of Ab-induced cytotoxicity and signiﬁcantly
increased cell viability (Fig. 1; Table 1). These results
demonstrate that the walnut extract can protect cells against
Ab-induced cytotoxicity.
Figure 2 represents Ab-induced LDH release into the
conditioned medium of PC12 cells with or without treat-
ment with walnut extract. LDH assay showed that Ab
released LDH from the cells in a concentration-dependent
manner, which was signiﬁcantly higher (P\0.05) at
75 lM than at 50 lMo fA b concentration. As shown in
Fig. 2 and Table 1, this effect of Ab was signiﬁcantly
inhibited by pretreatment of the cells with walnut extract (2
or 4 lg GAE). Our results suggest that treatment of the
cells with walnut extract protects against Ab-induced cell
membrane damage.
Effect of Walnut Extract on Ab-Induced DNA Damage
in PC12 Cells
Treatment of PC12 cells with 50 or 75 lMA b for 24 h
signiﬁcantly augmented DNA fragmentation (P\0.001)
as compared to control cells that were not treated with Ab
(Fig. 3; Table 1). This effect was signiﬁcantly higher at
75 lM than at 50 lMo fA b concentration (P\0.01). The
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Fig. 1 Effect of different concentrations of walnut extract on Ab-
induced cell death. Cell viability was assessed by MTT reduction
assay. *P\0.05, **P\0.01, ***P\0.001, one way-ANOVA
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Fig. 2 Effect of different concentrations of walnut extract on Ab-
induced cell membrane damage, assessed by LDH release. *P\0.05,
**P\0.01, ***P\0.001, one way-ANOVA
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Fig. 3 Effect of different concentrations of walnut extract on Ab-
induced DNA damage in PC12 cells. **P\0.01, ***P\0.001, one
way-ANOVA
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dramatically reduced the percentage of DNA fragmentation
induced by 50 and 75 lMA b (P\0.001) (Fig. 3;
Table 1). Since DNA fragmentation is indicative of apop-
totic cell death, these results suggest that walnuts may
prevent apoptosis induced by Ab.
Walnut Extract Inhibits Ab-Induced Generation of Free
Radicals (ROS) in Cells
To examine whether walnut extract can inhibit ROS gen-
eration induced by Ab, we studied the effects of walnut
extract on ROS levels in PC12 cells treated with Ab
(Fig. 4). Exposure of PC12 cells to 50 or 75 lMA b for
24 h resulted in a signiﬁcant increase of ROS levels
(P\0.001). The cells pretreated with 2 or 4 lg GAE of
walnut extract showed a signiﬁcant reduction in the ROS
levels. These results indicate that walnut extract can inhibit
Ab-mediated ROS production in PC12 cells.
Discussion
Oxidative stress [3–14] and inﬂammation [5, 14–16] are
prominent features in the pathophysiology of AD, which
may be causally related to neuronal dysfunction and death
in AD. The brains of individuals with AD had increased
levels of lipid peroxidation products such as 4-hydroxy-
nonenal or 2-propenal, and enhanced lipid peroxidation
was also detected in the cerebrospinal ﬂuid and plasma of
individuals with AD [4, 7, 10]. In addition, oxidative
damage to proteins and mitochondrial and nuclear DNA is
also an important event in AD pathology [4, 8, 11–13].
Increased oxidative damage has also been reported in the
early stages of mild cognitive impairment in the brains of
individuals with AD, and in cerebrospinal ﬂuid from
individuals with very early signs of dementia [14, 62].
The relationship between diet and health beneﬁts has
become increasingly obvious with accumulating evidence
that plant foods rich in phenols and ﬂavonoids are an
important class of defensive antioxidants [63–67]. Plant
extracts such as green tea, gingko biloba and curcumin
have been reported to prevent oxidative stress-mediated
apoptosis in cultured neurons, and also to reduce the oxi-
dative stress that is associated with AD [67–72]. Walnut
extract has been reported to inhibit Ab ﬁbrillization and to
solubilize Ab ﬁbrils [50]. In the present study, we report
for the ﬁrst time that walnut extract acts as a cytoprotective
agent against Aß-induced cytotoxicity.
Several studies have indicated that Ab induces apoptosis
and neuronal cell death by producing ROS, which leads to
the peroxidation of membrane lipids and oxidative stress
[17–21]. We also observed that Ab induces ROS genera-
tion in PC12 cells. Interestingly, the intracellular ROS
accumulation resulting from Ab treatment was signiﬁ-
cantly reduced when cells were treated with walnut extract
as compared to control cells treated with Ab only, which
clearly demonstrated that walnut extract has the ability to
scavenge oxygen radicals. ROS generation and the
0 2 4 0 2 4 0 2 4
0
10
20
30
40
50
60
70
80
90
Walnut (μg GAE)
Control (No Aβ) Aβ (50 μM) Aβ (75 μM)
***
***
**
**
**
*
R
O
S
 
l
e
v
e
l
s
(
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
)
Fig. 4 Effect of different concentrations of walnut extract on Ab-
induced free radical (ROS) generation in PC12 cells. ROS levels were
measured by DCF ﬂuorescence assay. *P\0.05, **P\0.01,
***P\0.001, one way-ANOVA
Table 1 Effect of Ab on cell death, apoptosis and free radical generation in the absence or presence of different concentrations of walnut extract
(WE) in PC12 cells
Ab-induced changes Ab (50 lM) Ab (75 lM)
No WE ?WE
(2 lg GAE)
?WE
(4 lg GAE)
Control
(No WE)
?WE
(2 lg GAE)
?WE
(4 lg GAE)
LDH release (increase in membrane
damage)
251.8% 155.4% 88.7% 357.3% 166.2% 140.9%
MTT (decrease in cell viability) -60.0% -46.8% -41.2% -62.1% -47.8% -45.1%
Apoptosis (fold increase in DNA
fragmentation)
47.1 5.2 5.1 64.9 7.0 7.6
ROS (increase in free radical generation) 79.1% 25.5% 12.5% 106% 44.9% 27.9%
The effect of Ab on LDH release, MTT reduction, DNA fragmentation and ROS levels in the absence or presence of walnut extract is calculated
in comparison to controls (no Ab)
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123resultant oxidative stress have been implicated widely in
the mechanism of Aß-induced cell death. It is also known
that ﬂavonoids, ellagic acid, melatonin and gamma
tocopherol, which are components of walnuts [26–32],
have antioxidative and free-radical scavenging properties
[63–67, 73, 74]. Because constituents of walnuts have
strong antioxidant properties, it is suggested that inhibition
of Ab-induced free radical generation by walnut extract
may be due to the neutralization of ROS. It has been
suggested that ﬂavonols and polyphenols can interact with
membrane phospholipids through hydrogen bonding to the
polar head groups of phospholipids, and thus protect the
integrity of the cell membrane from oxidative damage [75].
An upsurge in ROS production can also cause shifts in
the redox state of cells, which is associated with the
apoptotic pathway [76]. The increased reduction of MTT
and release of LDH upon treatment of the cells with Ab
that we observed suggests that Ab affects cell viability and
membrane damage. In addition, Ab induced DNA frag-
mentation in the cells that is indicative of apoptosis. Our
ﬁndings of Ab-mediated cytotoxicity and of DNA and
membrane damage are suggestive of the involvement of
apoptosis in Ab-induced cell death. The treatment with
walnut extract signiﬁcantly increased cell viability,
reduced the apoptosis induced by Ab and offered protec-
tion in PC12 cells. This protective effect of walnut extract
against Ab-mediated cytotoxicity in PC12 cells may be
attributed to the anti-oxidative capacity of different con-
stituents of walnuts.
The beneﬁcial effects of walnuts have also been impli-
cated in reducing the risk of coronary heart disease and
coronary vascular disease [38–41]. In addition, the poten-
tial beneﬁts of consumption of nuts in lowering the risk of
type 2 diabetes in women has been reported [47]. The role
of oxidative stress in the onset and progression of diabetes
is well documented. Some of the effects of the oxidative
environment include the development of insulin resistance,
dysfunction of the b cells of the pancreas, impaired glucose
tolerance and mitochondrial dysfunction, which may lead
to the diabetic condition [77]. Several studies have sug-
gested an inverse relationship between insulin sensitivity
and ROS levels. Reduction in oxidative stress by a diet rich
in walnuts may also help improve insulin sensitivity and
glucose metabolism.
In summary, our results suggest that walnut extract
offers protection against Ab- mediated cell death by
(1) reducing the generation of free radicals, (2) inhibiting
membrane damage and (3) attenuating DNA damage. This
effect of walnut extract could be due to the active com-
pounds present in walnuts, which may increase the capacity
of endogenous antioxidant defenses and may modulate the
cellular redox state. A diet rich in walnuts may therefore
reduce Ab-mediated cytotoxicity, neuronal loss and the
risk of developing AD.
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